Editas raises $90M in follow-on

Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) raised $90 million through the sale of 4 million shares at $22.50 in a follow-on underwritten by Morgan Stanley, JPMorgan, Cowen and JMP Securities. The price represents a 9% discount to Editas' closing price of $24.64 on Wednesday, when it proposed the offering after market hours. Editas priced the offering after market hours Thursday, when its shares closed at $24.91, and slipped $2.61 (10%) to $22.30 on Friday...